Key statistics
As of last trade Teleflex Inc (TFX:NYQ) traded at 191.17, 2.97% above its 52-week low of 185.66, set on Nov 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 191.42 |
---|---|
High | 193.49 |
Low | 190.46 |
Bid | 190.95 |
Offer | 191.39 |
Previous close | 190.64 |
Average volume | 457.51k |
---|---|
Shares outstanding | 46.44m |
Free float | 46.32m |
P/E (TTM) | 37.80 |
Market cap | 8.85bn USD |
EPS (TTM) | 5.04 USD |
Annual div (ADY) | 1.36 USD |
---|---|
Annual div yield (ADY) | 0.71% |
Div ex-date | Nov 15 2024 |
Div pay-date | Dec 16 2024 |
Data delayed at least 15 minutes, as of Nov 22 2024 16:49 GMT.
More ▼
- Teleflex to Present at the 36th Annual Piper Sandler Healthcare Conference
- Teleflex to Present at the Jefferies London Healthcare Conference
- Teleflex Announces Quarterly Dividend
- Teleflex Reports Third Quarter Financial Results and Full Year 2024 Outlook
- First Patient Enrolled in Teleflex’s Barrigel™ Rectal Spacer Trial for Post Radical Prostatectomy Radiation Therapy (PPRT)
- New Data Presented at ASTRO 2024 Further Demonstrate the Safety and Efficacy of Barrigel™ Rectal Spacer, the First and Only Sculptable Hyaluronic Acid Rectal Spacer, in Patients Undergoing Radiation Therapy for Prostate Cancer(1-3)
- Teleflex Announces Third Quarter 2024 Earnings Conference Call Information
- Teleflex’s Barrigel Rectal Spacer to Be Featured in Three Presentations at the 2024 American Society for Radiation Oncology (ASTRO) Annual Meeting
- Teleflex to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
- Teleflex Announces Publication of a Propensity Matching Review of Retrospective Data Reporting that the Titan SGS™ Stapler Enables Consistent Gastric Pouch Formation with Fewer Variations, Providing Potentially Enhanced Clinical Outcomes and Significant Procedural Efficiency Compared with Traditional Surgical Staplers
More ▼